Clinical Trials Browser

INDUSTRY × Sezary Syndrome × resminostat × Clear all

NCT02953301 2024-08-30

RESMAIN

Phase 2 Completed

DermatologicLymphoid

Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous